Document Detail

Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions.
MedLine Citation:
PMID:  18377526     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Gadolinium-enhanced cardiac magnetic resonance imaging has been used to show myocardial fibrosis, a finding that appears as late gadolinium enhancement. Its role in the evaluation of right ventricular fibrosis in congenital heart disease is unclear. The purpose of this study was to demonstrate late gadolinium enhancement of the right ventricle in adult and adolescent congenital heart disease and to investigate the relationship between this enhancement and clinical and pathophysiological data. DESIGN: In total, 24 patients, 16 patients with congenital heart disease and right ventricular loading conditions and 8 controls, underwent gadolinium-enhanced viability imaging. Diagnoses varied and included repaired, palliated, and unrepaired lesions. The presence and extent of right ventricular late gadolinium enhancement was compared with patient clinical and hemodynamic data. Exact Wilcoxon tests, Fisher's exact tests, and Spearman's rank correlation were used to compare variables. RESULTS: Nine of 16 patients (56%) were found to have right ventricular late gadolinium enhancement, ranging from 5% to 80% of right ventricular myocardium affected (mean 36.1%, SD 29.7). The combination of right ventricular systolic pressure >or=98 mm Hg and systemic oxygen saturation <or=93% strongly suggested the presence of right ventricular late gadolinium enhancement (positive predictive value 100%), but no single variable or combination of variables could reliably predict its absence (negative predictive values <or=75%). Extent of right ventricular late gadolinium enhancement did not correlate with degree of either hypoxia or right ventricular hypertension. CONCLUSIONS: Gadolinium-enhanced cardiac magnetic resonance demonstrates right ventricular late gadolinium enhancement in some patients with congenital heart disease and right ventricular loading conditions. Clinical variables were associated with the presence of fibrosis but did not reliably predict severity. Myocardial preservation is likely a multifactorial process that may affect the right and left ventricles differently.
Lopa P Hartke; Robert C Gilkeson; Mary Ann O'Riordan; Ernest S Siwik
Related Documents :
6185056 - Congenital heart disease in nigeria: a ten-year experience at uch, ibadan.
8028356 - A one-way, valved, atrial septal patch in the management of postoperative right heart f...
3114566 - Resorbable suture support for ventricular aneurysmectomy.
648576 - Echocardiographic estimation of a left-to-right shunt in isolated ventricular septal de...
10807456 - Remote myocardial dysfunction after acute anterior myocardial infarction: impact of lef...
16251226 - Impact of intracoronary aspiration thrombectomy during primary angioplasty on left vent...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Congenital heart disease     Volume:  1     ISSN:  1747-0803     ISO Abbreviation:  -     Publication Date:  2006 Sep 
Date Detail:
Created Date:  2008-04-01     Completed Date:  2008-05-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101256510     Medline TA:  Congenit Heart Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  192-201     Citation Subset:  IM    
Department of Internal Medicine, Case University/University Hospitals of Cleveland/Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Gadolinium / diagnostic use*
Heart Defects, Congenital / pathology*,  physiopathology
Heart Ventricles / pathology*
Image Enhancement
Magnetic Resonance Imaging / methods*
Middle Aged
Reg. No./Substance:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bartonella endocarditis in complex congenital heart disease.
Next Document:  The design and deployment of the HELEX septal occluder.